Teva Pharmaceutical Industries Limited Expected to Post Q3 2025 Earnings of $0.62 Per Share (NYSE:TEVA)
Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) – Analysts at Zacks Research raised their Q3 2025 earnings per share (EPS) estimates for Teva Pharmaceutical Industries in a research report issued to clients and investors on Wednesday, May 1st. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of […]